Active, not recruitingPhase 3

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

NCT06304883

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Xenoscience, Inc.

Phoenix, Arizona, United States

+40 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2024-04-02
Enrollment: 163 participants
Sponsor: Alzheon Inc.
Purpose: treatment

Locations (41)

Xenoscience, Inc.Phoenix, Arizona, United States
Banner Sun Health Research InstituteSun City, Arizona, United States
ATP Clinical ResearchCosta Mesa, California, United States
Torrance Clinical Research InstituteLomita, California, United States
Sutter HealthSacramento, California, United States
JEM Research Institute, Headlands SiteAtlantis, Florida, United States
K2 Medical Research, LLCMaitland, Florida, United States
Mount Sinai Medical CenterMiami Beach, Florida, United States
Aqualane Clinical ResearchNaples, Florida, United States
Charter ResearchOrlando, Florida, United States
Progressive Medical ResearchPort Orange, Florida, United States
ALZ Research and Treatment Center (A.R.T.C.)Stuart, Florida, United States
ALZ Research and Treatment Center (A.R.T.C.)Wellington, Florida, United States
Premiere Research InstituteWest Palm Beach, Florida, United States
Columbus Memory CenterColumbus, Georgia, United States
Fort Wayne Neurological CenterFort Wayne, Indiana, United States
Headlands Research Eastern MAPlymouth, Massachusetts, United States
Advanced Memory Research CenterToms River, New Jersey, United States
Neurological Associates of AlbanyAlbany, New York, United States
NYU Alzheimer's Disease Research CenterNew York, New York, United States
University of Rochester Medical CenterRochester, New York, United States
Triad Clinical TrialsGreensboro, North Carolina, United States
AMC ResearchMatthews, North Carolina, United States
Center for Cognitive HealthPortland, Oregon, United States
Abington Neurological AssociatesAbington, Pennsylvania, United States
Rhode Island Mood & Memory Research InstituteEast Providence, Rhode Island, United States
UT Health Science Center at HoustonHouston, Texas, United States
Re:Cognition HealthFairfax, Virginia, United States
Northwest Clinical Research CenterBellevue, Washington, United States
OCT Research ULC (dba Okanagan Clinical Trials)Kelowna, British Columbia, Canada
Centricity ResearchHalifax, Nova Scotia, Canada
Recherches Neuro-Hippocampe Inc., d/b/a Ottawa Memory ClinicOttawa, Ontario, Canada
Kawartha Centre - Redefining Healthy AgingPeterborough, Ontario, Canada
Toronto Memory ProgramToronto, Ontario, Canada
Re-Cognition Health Ltd PlymouthPlymouth, Devon, United Kingdom
Re-Cognition Health Ltd LondonLondon, Greater London, United Kingdom
NeuroClin Glasgow LtdMotherwell, North Lanarkshire, United Kingdom
Re-Cognition Health Ltd GuildfordGuildford, Surrey, United Kingdom
Re-Cognition Health Ltd BirminghamBirmingham, West Midlands, United Kingdom
Re-Cognition Health Ltd BristolBristol, United Kingdom
Re-Cognition Health Ltd WinchesterWinchester, United Kingdom